SOLARA ACTIVE PHARMA SCIENCES
SOLARA ACTIVE PHARMA SCIENCES Share Price Chart
SOLARA ACTIVE PHARMA SCIENCES last traded at ₹663.00 (2026-10-13). Over the past month the stock moved -6.1%, three months the stock moved +18.7%, year the stock moved -1.8%. Its closing range over 52 weeks is ₹441.25 – ₹753.00, with the latest close 12.0% below the high.
Closing prices up to 2026-10-13.
About SOLARA ACTIVE PHARMA SCIENCES
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.[1]
Product Offerings The company is a pure-play API manufacturer, offering a range of high-value commercial APIs and contract manufacturing services across 73+ countries. Its portfolio includes 60+ commercial APIs across key therapeutic segments, including anthelmintic, anti-malaria, anti-infective, etc. The top 10 molecules contribute to 84% of its total revenues. [1] [2] [3]
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), SOLARA ACTIVE PHARMA SCIENCES reported sales of ₹382.00 crore (+19.7%) and net profit of ₹16.00 crore (+45.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 382.00 | 62.00 | 16.00 | 16.00 | 3.41 |
| Mar 2026 | 387.00 | 58.00 | 15.00 | 10.00 | 2.65 |
| Dec 2025 | 349.00 | 37.00 | 11.00 | -17.00 | -4.82 |
| Sep 2025 | 314.00 | 35.00 | 11.00 | -10.00 | -2.79 |
| Jun 2025 | 319.00 | 57.00 | 18.00 | 11.00 | 2.91 |
| Mar 2025 | 273.00 | 45.00 | 17.00 | -2.00 | -0.58 |
| Dec 2024 | 300.00 | 58.00 | 19.00 | 8.00 | 2.24 |
| Sep 2024 | 347.00 | 61.00 | 18.00 | 8.00 | 2.22 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -18.4% | +41.5% | -8.7% | -12.1% | -9.5% | +16.3% | +41.8% | +19.7% |
| Operating profit growth | +60.5% | – | +350.0% | +35.7% | -42.6% | -36.2% | +28.9% | +8.8% |
| Net profit growth | – | – | – | – | -225.0% | -312.5% | – | +45.5% |
| EPS growth | – | – | – | – | -225.7% | -315.2% | – | +17.2% |
| OPM % | 18.0% | 19.0% | 17.0% | 18.0% | 11.0% | 11.0% | 15.0% | 16.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), SOLARA ACTIVE PHARMA SCIENCES reported sales of ₹1,369.00 crore (+6.6%) and net profit of ₹-7.00 crore (-800.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 1,369 | 187.00 | 14.00 | -7.00 | -2.05 |
| Mar 2025 | 1,284 | 206.00 | 16.00 | 1.00 | 0.15 |
| Mar 2024 | 1,289 | -95.00 | -7.00 | -567.00 | -118.21 |
| Mar 2023 | 1,444 | 134.00 | 9.00 | -22.00 | -4.62 |
| Mar 2022 | 1,268 | 81.00 | 6.00 | -58.00 | -12.11 |
| Mar 2021 | 1,617 | 386.00 | 24.00 | 221.00 | 46.22 |
| Mar 2020 | 1,322 | 260.00 | 20.00 | 115.00 | 32.01 |
| Mar 2019 | 1,387 | 213.00 | 15.00 | 59.00 | 17.30 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +166.2% | -4.7% | +22.3% | -21.6% | +13.9% | -10.7% | -0.4% | +6.6% |
| Operating profit growth | +273.7% | +22.1% | +48.5% | -79.0% | +65.4% | -170.9% | – | -9.2% |
| Net profit growth | – | +94.9% | +92.2% | -126.2% | – | – | – | -800.0% |
| EPS growth | – | +85.0% | +44.4% | -126.2% | – | – | – | -1466.7% |
| OPM % | 15.0% | 20.0% | 24.0% | 6.0% | 9.0% | -7.0% | 16.0% | 14.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for SOLARA ACTIVE PHARMA SCIENCES.
Get Free AI Stock Analysis FREE →Latest News
-
Solara Active Pharma Sciences FY26 Results: Revenue up 7% to ₹1,375.14 crore, net loss widens - scanx.trade
-
Solara Active Pharma Sciences consolidated net profit rises 55.04% in the June 2026 quarter - Business Standard
-
Solara Active Pharma spurts after reporting turnaround Q4 perfromance - Business Standard
-
Solara Active Pharma spurts after reporting turnaround Q4 perfromance - Business Standard
-
Solara Active Pharma Sciences Reappoints Internal and Cost Auditors for Financial Year 2026-27 - scanx.trade
-
Solara Active Pharma spurts after reporting turnaround Q4 perfromance - Business Standard
-
USFDA issues EIR with VAI classification to Solara Active Pharma Sciences’ Puducherry facility
Frequently Asked Questions
What is SOLARA ACTIVE PHARMA SCIENCES's current stock price?
SOLARA ACTIVE PHARMA SCIENCES shares were last quoted at ₹663.00 (+2.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of SOLARA ACTIVE PHARMA SCIENCES?
SOLARA ACTIVE PHARMA SCIENCES has a price-to-earnings (P/E) ratio of -4,616.87 and a price-to-book (P/B) ratio of 2.79. The industry P/E is 53.33.
What is the 52-week high and low of SOLARA ACTIVE PHARMA SCIENCES?
The 52-week high of SOLARA ACTIVE PHARMA SCIENCES is ₹774.00 and the 52-week low is ₹422.85.
What is the market cap of SOLARA ACTIVE PHARMA SCIENCES?
The market capitalisation of SOLARA ACTIVE PHARMA SCIENCES is about ₹3,550.04 crore.
How did SOLARA ACTIVE PHARMA SCIENCES perform in its latest quarterly results?
In the latest quarter (Jun 2026), SOLARA ACTIVE PHARMA SCIENCES reported sales of ₹382.00 crore (+19.7%) and net profit of ₹16.00 crore (+45.5%), compared with the same quarter last year.
Is SOLARA ACTIVE PHARMA SCIENCES a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, SOLARA ACTIVE PHARMA SCIENCES has a 3-year ROE of -12.00%, 3-year profit growth of 25.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in SOLARA ACTIVE PHARMA SCIENCES?
Promoters hold about 41.93% of SOLARA ACTIVE PHARMA SCIENCES.
Which sector does SOLARA ACTIVE PHARMA SCIENCES belong to?
SOLARA ACTIVE PHARMA SCIENCES belongs to the Pharmaceuticals & Drugs sector.